- Home
- FULC vs ILPT Comparison
FULC vs ILPT Comparison
Compare FULC & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FULC | ILPT |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.8M | 530.0M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FULC | ILPT |
|---|---|---|
| Price | $6.17 | $8.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $16.38 | $7.05 |
| AVG Volume (30 Days) | ★ 586.4K | 385.7K |
| Earning Date | 04-27-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.66% |
| EPS Growth | N/A | ★ 31.51 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.04 |
| Revenue Next Year | N/A | $2.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.90 | $3.01 |
| 52 Week High | $15.74 | $8.30 |
Technical Indicators
Market Signals| Indicator | FULC | ILPT |
|---|---|---|
| Relative Strength Index (RSI) | 31.50 | 67.05 |
| Support Level | N/A | $5.15 |
| Resistance Level | $7.09 | $8.25 |
| Average True Range (ATR) | 0.41 | 0.41 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 0.00 | 78.67 |
Price Performance
Historical ComparisonAbout FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.